Infectious Disease Frontier Archives - Page 7 of 35

Dr. Tao Chen: Insights on the “Expert Consensus on Thymosin Alpha-1 in Infectious Diseases and Critical Illness” | CCIFLDI 2024

By Mourabit Halima 2024.11.08

Editor’s Note: With growing attention to immunotherapy, thymosin alpha-1 (Tα1), a bioactive peptide composed of 28 amino acids with immunomodulatory effects, is increasingly applied in infectious diseases and critical care.…

Consensus from SIDP: Primary Prevention and Therapeutic Drug Monitoring (TDM) for Triazole Antifungal Drugs

By Lisa Cui 2024.11.01

Introduction: The Society of Infectious Disease Pharmacists (SIDP) presents its consensus recommendations for primary prevention and therapeutic drug monitoring (TDM) of five commonly used triazole antifungal drugs: voriconazole, posaconazole, itraconazole,…

Klebsiella pneumoniae: Leading Bacterial Killer in Clinical Settings – Dr. Chen Sheng Shares Advances at One Health Conference

By Mourabit Halima 2024.10.30

Editor’s Note: Klebsiella pneumoniae is a significant opportunistic pathogen capable of causing a range of infections, including pneumonia, urinary tract infections, bloodstream infections, and sepsis. In particular, infections caused by…

One Health: United Efforts to Combat Resistance丨The Second One Health Antimicrobial Resistance Control Conference Kicks Off in Hangzho

By Lisa Cui 2024.10.23

Editor’s Note: With the crisp autumn breeze and the sweet fragrance of osmanthus in the air, the Second One Health Antimicrobial Resistance Control Conference, hosted by the Zhejiang Pharmaceutical Association…

Dr. Yonghong Xiao: From Concept to Action, Implementing One Health Strategies and Multidisciplinary Cooperation | Chairperson Interview

By Peng Longmei 2024.10.21

Editor’s Note: Antimicrobial resistance (AMR) continues to challenge global public health, demanding human ingenuity and collaboration. The One Health concept has emerged as a key strategy to curb AMR. Recently,…

ESCMID-EUCIC | Guidelines on Preoperative Decolonization and Targeted Prevention for MDR Gram-Positive Bacteria

By Siqi Wang 2024.10.20

Editorial Note: Surgical site infections (SSIs) are among the most common postoperative complications, not only prolonging hospital stays and increasing medical costs but also severely impacting patient survival and quality…

Non-KPC Characteristics of Novel BL/BLI Compounds in Pseudomonas aeruginosa

By Mourabit Halima 2024.10.17

Editor's Note: In the previous article, we provided a detailed overview of the advancements in the use of novel β-lactam/β-lactamase inhibitor (BL/BLI) combinations in Enterobacterales with various resistance mechanisms. This…

New Characteristics of BL/BLI Compounds Targeting Non-KPC Enterobacterales

By Peter W. PENG 2024.10.16

Editor's Note: As carbapenem-resistant Gram-negative bacteria (CRO) have become increasingly prevalent, the development and application of novel β-lactam/β-lactamase inhibitor (BL/BLI) combinations have gained significant attention from researchers worldwide. A recent…

Insights from Dr. Khalil Ghanem on the Challenges and Future of Syphilis Diagnosis, Treatment, and Prevention

By Ren Jiamo 2024.10.15

Editor's Note: As the incidence of syphilis continues to rise, clinicians are faced with an increasing number of patients with complex clinical presentations, posing significant challenges in patient management. At…

Application of carbapenems in the treatment of MDR-GNB and management of drug resistance

By Mourabit Halima 2024.10.15

Editor's note: With the increase in multi-drug resistant Gram-negative bacterial infections (MDR-GNB) worldwide, the use strategy of carbapenems as key drugs for the treatment of such infections has received widespread…